AI Detection of Incidental Coronary Artery Calcium to Enhance Cardiovascular Disease Prevention
AI Detection of Incidental Coronary Artery Calcium to Enhance Cardiovascular Disease Prevention: A Multicenter Randomized Trial
Brigham and Women's Hospital
1,500 participants
Jul 31, 2024
INTERVENTIONAL
Conditions
Summary
AI INFORM is a multicenter randomized trial that will test the hypothesis that providing clinicians information on the presence and amount of coronary artery calcifications (CAC), will result in initiation or intensification of preventive therapies. The study will use a cloud-based artificial intelligence (AI) platform (Nanox.AI) that can analyze non contrast chest CT and estimate the amount of CAC.
Eligibility
Inclusion Criteria1
- Patients aged between 40-75 with prior chest CT within last 3 years
Exclusion Criteria3
- Prior coronary artery disease
- Prior cancer
- Other life-limiting condition
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
The intervention involves electronic health record, email, or letter notification about the presence of coronary artery calcification on chest CT and recommendation of preventive therapy. This is based on results of the automatic detection of coronary artery calcification from AI device (software).
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06235112